Privileged Scaffolds in Drug Discovery

Privileged Scaffolds in Drug Discovery is a comprehensive and up-to-date work that covers a wide range of privileged structures, making it a perfect reference for scientists involved in targeted drug development. The book includes contributions from experts from prestigious Chinese institutions and explores scaffolds in drug molecules approved in recent years.

Format: Paperback / softback
Length: 986 pages
Publication date: 20 July 2023
Publisher: Elsevier Science Publishing Co Inc

Privileged Scaffolds in Drug Discovery is a comprehensive and cutting-edge work in the field, covering a wide range of privileged structures. It serves as an invaluable resource for scientists engaged in targeted drug development. The editors have assembled a team of esteemed experts from prestigious Chinese institutions to delve into various areas, including antiviral drugs, chalcones, pyrimidines, (benz)imidazoles, natural product-derived privileged scaffolds, N-Sulfonyl carboxamides, kinase inhibitors, antitumor molecules, antineurodegenerative drugs, triazoles, oxazolidinone, indole, and indoline scaffolds, tigliane diterpenoids, peptide and peptide-based drugs, quassinoids, and others, including pseudonatural products, macrocycles, stable peptides, and peptidomimetics.

The book also delves into scaffolds in drug molecules that have been approved in recent years. Privileged Scaffolds in Drug Discovery is a must-have for researchers in drug discovery and organic synthesis, whether they are working in academic or corporate settings. It provides valuable insights and information for those investigating privileged structures as potential bases for new drugs. Researchers in medicinal chemistry and chemical biology will also find this book highly informative and useful.

Weight: 450g
Dimension: 276 x 216 (mm)
ISBN-13: 9780443186110